Your browser doesn't support javascript.
loading
Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer.
Sebastian, Nikhil; Wu, Trudy; Driscoll, Erin; Willers, Henning; Kelly, Suzanne; Musunuru, Hima Bindu; Mo, Xiaokui; Tan, Yubo; Bazan, Jose; Haglund, Karl; Xu-Welliver, Meng; Baschnagel, Andrew M; Ju, Andrew; Keane, Florence; Williams, Terence M.
Affiliation
  • Sebastian N; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, USA.
  • Wu T; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, USA.
  • Driscoll E; Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA.
  • Willers H; Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA.
  • Kelly S; Department of Radiation Oncology, East Carolina University Brody School of Medicine, Greenville, USA.
  • Musunuru HB; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, USA.
  • Mo X; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Tan Y; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Bazan J; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, USA.
  • Haglund K; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, USA.
  • Xu-Welliver M; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, USA.
  • Baschnagel AM; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, USA.
  • Ju A; Department of Radiation Oncology, East Carolina University Brody School of Medicine, Greenville, USA.
  • Keane F; Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA.
  • Williams TM; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, USA. Electronic address: Terence.Williams@osumc.edu.
Radiother Oncol ; 140: 26-33, 2019 11.
Article in En | MEDLINE | ID: mdl-31176206
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bicarbonates / Radiosurgery / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Radiother Oncol Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Irlanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bicarbonates / Radiosurgery / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Radiother Oncol Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Irlanda